Yenda Manishankar* and Mukthinuthalapati Mathrusri Annapurna
GITAM Institute of Pharmacy, GITAM (Deemed to be University), Visakhapatnam, India
*Corresponding Author: Yenda Manishankar, GITAM Institute of Pharmacy, GITAM (Deemed to be University), Visakhapatnam, India.
Received: November 19, 2020; Published: December , 2020
Rilpivirine is an Anti-viral drug. Rilpivirine acts by inhibiting the replication of HIV – 1 by binding in a non – competitive manner directly to reverse transcriptase enzyme. In the present paper the authors have presented a review of various analytical methods published so far in the literature for the quantification of Rilpivirine in pharmaceutical preparations as well as biological samples.
Keywords: Rilpivirine; HIV; Anti-viral Drug
Citation: Yenda Manishankar and Mukthinuthalapati Mathrusri Annapurna. “The Residency Advisory Committee: Steering Pharmacy Postgraduate Training". Acta Scientific Pharmaceutical Sciences 5.1 (2021): .
Copyright: © 2021 Yenda Manishankar and Mukthinuthalapati Mathrusri Annapurna. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.